Adapting disease prevention protocols for human spaceflight during COVID-19/ Petersen, Eric; Pattarini, James M.; Mulcahy, Robert A.; Beger, Samuel B.; Mitchell, Matthew R.; Hu, Yiyuan David; Middleton, Kathryn N.; Frazier, Weston; Mormann, Benjamin; Esparza, Haley; Asadi, Amran; Musk, Elon R.; Alter, Galit; Nilles, Eric; Menon, Anil S.
Material type: TextPublication details: 2021Subject(s): Online resources: In: Aerospace Medicine and Human Performance Vol 92, No. 7, July 2021, pp. 597-602 (62)Summary: The National Aeronautics and Space Administration (NASA) Flight Crew Health Stabilization Program (HSP) was historically implemented to minimize infectious disease transmission to astronauts in the immediate prelaunch period. The first ever commercial application and adaptation of the NASA HSP was implemented during the Crew Demo-2 mission in the time of the Coronavirus disease 2019 (COVID-19) pandemic. This article details and discusses the first commercial implementation and adaptation of the HSP prior to the Crew Demo-2 launch.Item type | Current library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|
Journal Article | Mindef Library & Info Centre Journals | COVID-19 (Browse shelf(Opens below)) | 1 | Not for loan | 66951.1001 |
The National Aeronautics and Space Administration (NASA) Flight Crew Health Stabilization Program (HSP) was historically implemented to minimize infectious disease transmission to astronauts in the immediate prelaunch period. The first ever commercial application and adaptation of the NASA HSP was implemented during the Crew Demo-2 mission in the time of the Coronavirus disease 2019 (COVID-19) pandemic. This article details and discusses the first commercial implementation and adaptation of the HSP prior to the Crew Demo-2 launch.
COVID-19, HEALTH
There are no comments on this title.